Although the deposition of insoluble Aβ plaques and tau NFTs in the brain serve as pathological hallmarks in AD, recent evidence of the detrimental role of oligomers and the lack of accessible and reliable chemical tools for their detection has resulted in increased recent efforts towards developing fluorescent probes to detect these soluble, toxic oligomeric species. The gene discussed is MAPT; the disease is Alzheimer disease.